Introduction
============

Although numerous cases of serious neonatal infection by Lancefield streptococcal groups A, B, C, D, F, and G have been reported, there have been few reports of serious neonatal infection caused by nonenterococcal group D streptococci such as *Streptococcus bovis* group strains[@B1]. In adults, *S. bovis* group strains are known to cause bacteremia and endocarditis, and are associated with gastrointestinal malignancy[@B2],[@B3],[@B4]. There have been sporadic reports of meningitis and septicemia caused by *S. bovis* group strains in young infants[@B5],[@B6],[@B7]. We report a case of late-onset neonatal *S. bovis* meningitis and septicemia with central nervous system complications.

Case report
===========

A 28-day-old male infant was admitted to Korea University Ansan Hospital with a 1-day history of fever, lethargy, and moaning sounds. He was born at term (gestational age 38 weeks and 4 days, weight 3,600 g) via vaginal delivery after an uncomplicated pregnancy. He had been in good health until he developed a fever of 38.0℃ the day before admission. Physical examination was unremarkable except for a body temperature of 38.7℃. He was alert with an open and flat anterior fontanelle, normal grasp reflexes, normal neuromuscular tone, no neck stiffness, and no skin eruptions. Chest radiography findings were normal. His peripheral white blood cell (WBC) count was 5,120/dL (neutrophils 46.5%, lymphocytes 40.4%, monocytes12.7%) and his C-reactive protein level was 13.48 mg/dL. A lumbar puncture was performed and cerebrospinal fluid (CSF) analysis showed marked pleocytosis with a WBC count of 4,000/µL (neutrophils 78%, lymphocytes 8%), red blood cell (RBC) count of 440/µL, protein concentration of 319 mg/dL, and glucose concentration of 4 mg/dL. The CSF/serum glucose ratio was 0.03 (normal value 0.6). Cultures of blood, CSF, and urine obtained by bladder puncture grew *S. bovis* group strains on day 5, despite absence of pyuria. Empirical antibiotic treatment was initiated immediately after admission with intravenous ampicillin 300 mg/kg/day and cefotaxime 200 mg/kg/day. The cultured bacteria were sensitive to penicillin, cefotaxime, and clindamycin. Amplification and sequencing of ribosomal RNA identified *S. gallolyticus* subsp. *pasteurianus*.

The patient was afebrile from day 5 and received a total of 21 days of intravenous ampicillin and cefotaxime. CSF analysis on days 4 and 12 showed low WBC count of 130 cells/µL and 15 cells/µL, respectively. Repeat bacterial cultures of blood, CSF, and urine grew no pathogens. He was discharged on day 21 with a bilateral reduction in visual evoked potentials, but no empyema or subdural effusion on cranial ultrasonography.

Two weeks after discharge, the patient was rehospitalized with a 2-day history of fever and a 1-day history of seizure activity. He had a mild fever with a maximum temperature of 37.8℃. Several episodes of tonic-clonic movements of the left arm and leg were observed, each lasting a few seconds. A lumbar puncture was performed, and CSF analysis showed pleocytosis with a WBC count of 70/µL (neutrophils 11%, lymphocytes 31%, mononuclear cells 56%), RBC count of 970/µL, protein concentration of 339 mg/dL, and glucose concentration of 33 mg/dL. The CSF/serum glucose ratio was 0.3. Brain magnetic resonance imaging showed marked bilateral frontal subdural effusion ([Fig. 1](#F1){ref-type="fig"}). Ultrasound-guided needle aspiration of the effusion was performed on days 6 and 20. Analysis of the aspirated fluid on day 6 showed pleocytosis with a WBC count of 780/µL, RBC count of \>10,000/µL, protein concentration of 2,564 mg/dL, and glucose concentration of 70 mg/dL. On day 20, the CSF WBC count was 15/µL, RBC count was \>10,000/µL, protein concentration was 2,944 mg/dL, and glucose concentration was 83 mg/dL. Bacterial cultures of the aspirated effusion grew no pathogens. He was discharged after 31 days of intravenous ampicillin and cefotaxime. At follow-up after 9 months, his visual evoked potentials were improved and no neurological sequelae were observed.

Discussion
==========

*S. bovis* group strains are gram-positive bacteria that form part of the normal colonic flora in some individuals. These organisms are most recognized for causing endocarditis in adults, and their association with colonic neoplasms[@B3]. Sporadic cases of invasive infection with *S. bovis* group strains have been described in young infants and neonates[@B8].

Group D streptococci are well known to cause newborn septicemia and meningitis, especially *Enterococcus* spp.[@B5]. In contrast, *S. bovis* group strains are uncommon neonatal pathogens. Headings et al.[@B5] first described *S. bovis* infection in a neonate in 1978. A literature search produced only six reported cases of nonenterococcal group D streptococcal meningitis in the English literature from the late 1980s to the 2000s[@B9]. From 2000 to 2011, eight cases of *S. bovis* meningitis were reported in the English literature[@B10]. To our knowledge, this is the first report of *S. bovis* septicemia and meningitis in a Korean neonate or infant. The frequency of *S. bovis* infection may be underestimated, because *S. bovis* can be mislabeled as enterococci or viridians group streptococci.

Central nervous system complications of *S. bovis* group infection have rarely been reported. Klatte et al.[@B11] reported four infants with meningitis caused by *S. gallolyticus* subsp. *pasteurianus*. Although two of these infants presented with seizure-like activity, there were no neurological sequelae. Neurological complications are rare in adult cases of *S. bovis* meningitis[@B12]. Only one adult case of *S. bovis* meningitis with neurological complications has been reported, in a 70-year-old alcoholic with underlying central nervous system disease, who developed subdural empyema after 14 days of treatment with penicillin G. In our case, the patient developed seizure activity after 21 days of antibiotic therapy because of subdural effusion. These cases indicate that *S. bovis* group meningitis may have some similar presentations to group B streptococcal meningitis, such as delayed subdural effusion. *S. bovis* generally seems to be sensitive to penicillin, and neither abscess nor empyema formation occurred.

Neonatal *S. bovis* group infection has a similar clinical presentation to group B streptococcal infection[@B5]. Bacteremia is the most common clinical manifestation of early-onset *S. bovis* group infection, with meningitis being less common[@B8]. Neonates with early-onset *S. bovis* group bacteremia generally present with acute onset of respiratory distress and sepsis within the first 5 days of life[@B1]. In contrast, late-onset *S. bovis* group infection generally presents with urinary sepsis or meningitis[@B9]. Early-onset *S. bovis* infection might result from the intrapartum transmission of bacteria[@B2], but the pathogenesis of late-onset invasive *S. bovis* infection in infants is unclear. Fikar and Levy[@B1] reported that the pathogenic organism infecting their patient was also grown from rectal and vaginal cultures from the patient\'s mother. Unfortunately, we did not collect samples for bacterial culture from our patient\'s mother.

*S. bovis* group bacteria include two biotypes: *S. bovis* I (*S. gallolyticus*) and *S. bovis* variant or *S. bovis* II. *S. bovis* II includes two sub-biotypes: *S. bovis* II/1 (*S. infantarius*) and *S. bovis* II/2 (*S. pasteurianus*)[@B13]. Preliminary studies of the *S. bovis* biotypes isolated from patients suggest that specific biotypes are associated with specific clinical manifestations[@B8],[@B11]. Ruoff et al.[@B14] demonstrated that *S. bovis* I was most often associated with endocarditis and malignant or premalignant colonic lesions. In contrast, *S. bovis* II was associated with meningitis or neonatal infection. The reasons for these differences may include virulence factors of the specific organisms, host susceptibility, and differences in maternal colonization. Kim et al.[@B3] reported a patient with infective endocarditis caused by *S. bovis* I (*S. gallolyticus* subsp. *gallolyticus*) and underlying colon cancer, Jeong et al.[@B15] reported a case of severe septic shock caused by *S. bovis* II/2 (*S. gallolyticus* subsp. *pasteurianus*) infection in an adult, and Onoyama et al.[@B8] described neonatal bacteremia and meningitis caused by *S. bovis* II/2 infection. We performed biotyping of the organism cultured from our patient by amplification and sequencing of the ribosomal RNA, and identified it as *S. bovis* biotype II/2. The differentiation of biotypes in the *S. bovis* group may provide a useful predictor of disease progression.

*S. bovis* group infection appears to have a relatively good prognosis and a low mortality rate[@B9]. Although our patient developed delayed-onset subdural effusion and bilateral reduction of visual evoked potentials, subsequent follow-up did not reveal any neurological sequelae. His cognitive and developmental milestones will be followed up for several years.

In conclusion, we report a complicated case of neonatal *S. gallolyticus* subsp. *pasteurianus* infection causing urinary tract infection, septicemia, and meningitis.
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